Cumberland Partners’s Pediatrix Medical MD Stock Holding History

Cumberland Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,000	Closed	-$649K	–	197
2018 Q2	$649K	Buy	+15,000	New	+$719K	0.07%	125

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Cumberland Partners's MD Position: Q3 2018 in Review

Cumberland Partners sold out of Pediatrix Medical (MD) in Q3 2018, closing a stake of 15,000 shares — an estimated $649K sold.

Cumberland Partners first reported a position in MD in Q2 2018 and held it in 1 quarter. The position peaked at $649K in Q2 2018. 320 funds tracked by Wall St. Rank hold MD as of Q3 2018.

Cumberland Partners reported no remaining Pediatrix Medical position as of Q3 2018 after selling out during the quarter.
Cumberland Partners sold 15,000 Pediatrix Medical shares in Q3 2018, an estimated $649K.
Cumberland Partners first reported a position in Pediatrix Medical in Q2 2018 and held it in 1 quarter.
Cumberland Partners's Pediatrix Medical position peaked at $649K in Q2 2018.
320 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2018.

Based on Cumberland Partners's 13F filing for Q3 2018, filed 15 Nov 2018.